T4期肺癌主动脉受累的一期胸主动脉腔内修复术
单中心回顾性研究纳入2012年1月至2019年12月间在肿瘤切除术前接受胸主动脉腔内修复术的连续患者,共9例(7例T4期肺癌、1例肉瘤、1例胸腺瘤),中位随访25个月(范围22-47个月),无移植物相关并发症,除1例外均获R0切除,末次随访时8例存活且无复发。作者认为该技术是可行选择,可避免体外循环及其相关并发症,或可作为侵犯胸主动脉肿瘤的替代策略。
要点
- 9例侵犯胸主动脉的胸部肿瘤患者在肿瘤切除术前接受胸主动脉腔内修复术。
- 中位随访25个月(范围22-47个月),无移植物相关并发症。
- 除1例外均实现R0肿瘤切除,末次随访时8例存活且无复发。
核心结论
- 对于侵犯主动脉的胸部肿瘤患者,在手术切除前使用胸主动脉支架移植是可行的选择,可避免体外循环及其相关并发症。
- 该技术或可作为侵犯胸主动脉肿瘤治疗的替代策略。
研究设计与样本
- 单中心回顾性研究,回顾了2012年1月至2019年12月间所有在肿瘤切除术前接受胸主动脉腔内修复术的连续患者。
- 纳入标准为T4期肺部肿瘤或侵犯胸主动脉的纵隔肿瘤,共纳入9例患者:7例T4期肺癌、1例肉瘤、1例胸腺瘤。
主要发现
- 中位随访25个月(范围22-47个月)。
- 无移植物相关并发症。
- 除1例外所有患者均实现R0肿瘤切除。
- 末次随访时8例患者存活且无复发。
临床怎么用
- 作者认为,对于侵犯主动脉的胸部肿瘤患者,在手术切除前使用胸主动脉支架移植是可行的选择,可避免体外循环及其相关并发症。
- 作者认为该技术或可作为侵犯胸主动脉肿瘤治疗的替代策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of the study was to present the results in patients with a T4 thoracic tumor with aortic involvement who were treated with a thoracic endograft before surgical resection. DESCRIPTION: All consecutive patients undergoing a thoracic endograft procedure before an oncologic resection between January 2012 and December 2019 were reviewed in a single-center retrospective study. Included patients had either a T4 lung tumor or a mediastinal tumor invading the thoracic aorta. EVALUATION: Nine patients were included: 7 with T4 lung cancer, 1 with sarcoma, and 1 patient with thymoma. Median follow-up was 25 months (range, 22-47 months). There were no endograft-related complications. All but 1 patient had an R0 oncologic resection. Eight patients were alive and free from recurrence at the last follow-up. CONCLUSIONS: Use of thoracic stent grafting before surgical resection for patients with a thoracic tumor invading the aorta is a feasible option that obviates the need for extracorporeal circulation and its associated morbidity. This technique could be an alternative strategy in the treatment of tumors invading the thoracic aorta.
引用
- Danial P, Crawford S, Mercier O, et al. Primary Thoracic Endografting for T4 Lung Cancer Aortic Involvement. Ann Thorac Surg. 2022. PMID: 36122698. doi:10.1016/j.athoracsur.2022.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。